| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |